Metformin-imeglimin combo boosts glucose control in diabetes

12/13/2012 | PhysiciansBriefing.com

Type 2 diabetes patients who used imeglimin as an add-on to metformin treatment showed better fasting plasma glucose and proinsulin/insulin ratio compared with those on metformin-placebo therapy, according to a study in Diabetes Care. Metformin-imeglimin treatment was generally well-tolerated and showed a similar safety profile to that of metformin-placebo treatment, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA